RE: GSK Bribery Case in China - Part 1: Pharmaceutical Industry Overview: M&As, R&D and competition

You are viewing a single comment's thread from:

GSK Bribery Case in China - Part 1: Pharmaceutical Industry Overview: M&As, R&D and competition

in pharmaceutical •  7 years ago 

Thank you very much, @steemitboard!

pharmaceutical
7 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!